Latest News & Features
Asia
Police in the Philippines have raided a call centre in Manila whose operators had allegedly been selling counterfeit drugs, including copies of Pfizer’s Viagra (sildenafil), over the phone. 10 June 2015
Americas
The US Court of Appeals for the Federal Circuit has sent a patent dispute between drugs companies Shire and Watson Pharmaceuticals back to a district court, ruling again that the lower court erroneously construed claims related to Lialda. 10 June 2015
Big Pharma
Pfizer has apologised to UK-based healthcare providers for any confusion or increased workload following the English High Court’s decision on a patent infringement case centring on its epilepsy drug Lyrica. 9 June 2015
Americas
Hedge fund manager Kyle Bass has filed another petition for an inter partes review of a patent covering Horizon Pharma’s arthritis drug Vimovo. 9 June 2015
Big Pharma
The English High Court has ordered Novartis to pay 75% of the defendants’ legal costs in a patent infringement case against Focus Pharmaceuticals, Actavis and Teva. 8 June 2015
Americas
The US Court of Appeals for the Federal Circuit has heard oral arguments in Amgen v Sandoz, a case that should determine whether it is mandatory for biosimilar applicants to engage in the so-called patent dance. 8 June 2015
Americas
The Biotechnology Industry Organization has supported potential amendments to the Protect American Talent and Entrepreneurship Act, which was approved by the Senate Judiciary Committee yesterday. 5 June 2015
Americas
US law firm Taylor English has added Kelly Mullally to its intellectual property practice in Atlanta. 5 June 2015
Americas
California-based pharmaceutical company Prometheus Laboratories has asked the US Court of Appeals for the Federal Circuit to reinstate a patent covering its irritable bowel syndrome drug Lotronex. 4 June 2015
Europe
To opt out or not, that is the question for patentees under the new Unified Patent Court system, say Paul England and Anja Lunze of Taylor Wessing, in the third installment of a regular column on the unitary patent and UPC. 4 June 2015